Nom du produit:3,4-Dihydro-2H-pyrano[2,3-c]pyridine-6-carbaldehyde

IUPAC Name:2H,3H,4H-pyrano[2,3-c]pyridine-6-carbaldehyde

CAS:527681-61-4
Formule moléculaire:C9H9NO2
Pureté:95%+
Numéro de catalogue:CM253424
Poids moléculaire:163.18

Unité d'emballage Stock disponible Prix($) Quantité
CM253424-250mg in stock ȅǑǑ
CM253424-1g 1-2 Weeks ǫŞǫ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:527681-61-4
Formule moléculaire:C9H9NO2
Point de fusion:-
Code SMILES:O=CC1=CC(CCCO2)=C2C=N1
Densité:
Numéro de catalogue:CM253424
Poids moléculaire:163.18
Point d'ébullition:287.8±28.0°C at 760 mmHg
N° Mdl:MFCD18802894
Stockage:Keep in Inert atmosphere, store in freezer, under -20°C.

Column Infos

Gepotidacin
GSK announces positive headline results from the EAGLE-1 Phase III trial for Gepotidacin in uncomplicated urogenital gonorrhea. Gonorrhoea is the second most common sexually transmitted infection due to the pathogen N. gonorrhoeae. Untreated urogenital gonorrhea can cause serious and permanent health problems, such as pelvic inflammatory disease and infertility.
Gepotidacin is an investigational, first-in-class inhibitor of bacterial topoisomerase. It has a distinct mechanism of action that inhibits bacterial DNA replication by selectively interacting with two key bacterial enzymes, DNA gyrase and topoisomerase IV. Gepotidacin confers activity against most strains of E. coli and S. saprophyticus, and N. gonorrhoeae, including target pathogens resistant to current antibiotics.